Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation
The Firm is currently investigating Pradaxa lawsuits on behalf of individuals who allegedly suffered serious internal bleeding, a potentially deadly Pradaxa side effect.
New York, New York (PRWEB) May 19, 2013
The Pradaxa lawyers at Bernstein Liebhard LLP note that a Case Management Conference was recently convened for hundreds of Pradaxa bleeding lawsuits pending in a federal multidistrict litigation now underway in U.S. District Court, Southern District of Illinois. According to Minutes posted on the Court´s website on May 14th, the Conference addressed the status of depositions and pending motions. It was also reported during the Conference that Defendants submitted a list of early trial eligible cases to the Court and Plaintiffs´ co-lead counsel last month, and that the parties have revised and finalized the list. ( In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation — MDL No. 2385)
“We are pleased to see the federal Pradaxa litigation moving forward. We continue to receive inquiries from Pradaxa users who have allegedly suffered frightening episodes of internal bleeding while being treated with this blood thinner,” said Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm´s Pradaxa lawyers are currently offering free legal evaluations to alleged victims of Pradaxa bleeding.
Pradaxa Side Effect Lawsuits
Court records indicate that 711 Pradaxa lawsuits are currently pending in the Southern District of Illinois. All of the lawsuits allege Boehringer Ingelheim failed to adequately warn that there is no readily-available antidote for Pradaxa bleeding. The first trial in the litigation is scheduled to start in September 2014.
Pradaxa was approved for sale by the U.S. Food & Drug Administration (FDA) in October 2010 to prevent strokes in people with atrial fibrillation, and was supposed to provide an improved alternative to warfarin. But according to a report published by Bloomberg.com in December, regulators in several countries have issued Pradaxa bleeding alerts since the drug´s launch. One real danger is the fact that there exists no readily-available antidote for internal bleeding, a potentially life-threatening Pradaxa side effect. *
On May 1st, the Journal of Neurosurgery published a study that showed head trauma victims were more likely to die from brain bleeding if they had been using Pradaxa compared to those taking warfarin. The authors of the research said that the absence of an effective reversal agent could account for the higher death rate among Pradaxa patients.** In January, an analysis of FDA hemorrhage cases published in the Institute for Safe Medication Practice´s QuarterWatch report revealed Pradaxa bleeding was 5 times more likely to have a fatal outcome compared to warfarin bleeding.***
Victims of serious Pradaxa side effects may be eligible to collect compensation for their medical bills, lost wages, pain and suffering and more. Additional information regarding Pradaxa lawsuits is available at Bernstein Liebhard LLP´s website. To arrange for a free legal consultation with a Pradaxa lawyer, please call 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs´ Hot List,” recognizing the top plaintiffs´ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
For the original version on PRWeb visit: http://www.prweb.com/releases/prwebpradaxa-bleeding/pradaxa-lawyer/prweb10747155.htm